General
Alzheimer’s drug Lecanemab approved by Therapeutic Goods Administration for use in Australia
A promising new Alzheimer’s drug has been green-lit by the national medicines regulator, after two previous failed attempts to register it for use in Australia.
Lecanemab, sold under the brand name Leqembi, has been shown to clear amyloid plaque in the brain, which experts believe plays a role in…
Continue Reading
-
General21 hours agoSuper Typhoon Ragasa lashes Taiwan, with two dead and 30 missing
-
Business17 hours agoHow to spot the next WiseTech or Pro Medicus on the ASX
-
Business19 hours agoBHP and these ASX 200 shares could rise 15% to 30%
-
Noosa News16 hours agoCanola crop invaders seeking social media selfies told to stay off farms